Literature DB >> 15588225

Expanding role of T-cell costimulators in regulatory T-cell function: recent advances in accessory molecules expressed on both regulatory and nonregulatory T cells.

Lishomwa C Ndhlovu1, Ikuo Takeda, Kazuo Sugamura, Naoto Ishii.   

Abstract

A subpopulation of T cells harbors a suppressor phenotype and can significantly dampen autoreactive CD4+ and CD8+ T-cell responses. These regulatory T (Treg) cells, which can arise naturally in the thymus and encompass a CD25+CD4+ T-cell repertoire or be antigenically induced, are central players in the maintenance of self-tolerance. A plethora of O-cell costimulatory and accessory receptor molecules expressed by Treg and/or non-regulatory T cells, such as GITR, OX40, and CTLA-4, are involved in modulating the pathogenesis of numerous autoimmune disorders, transplant rejection, and tumor immunity, as well as the control of infections. Exciting new evidence shows that O-cell costimulators, some of which are identified as hopeful discriminative Treg-cell markers, appear to mediate Treg-cell homeostasis and function. Understanding the biological significance of the O-cell costimulatory molecules and the accessory molecules expressed by Treg cells is a prerequisite to better characterizing this regulatory T-cell population. We provide a synopsis of the current understanding of several costimulatory molecules that can orchestrate the function of both naturally arising and antigen-inducible Treg cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15588225     DOI: 10.1615/critrevimmunol.v24.i4.30

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  8 in total

Review 1.  The development and function of regulatory T cells.

Authors:  Creg J Workman; Andrea L Szymczak-Workman; Lauren W Collison; Meenu R Pillai; Dario A A Vignali
Journal:  Cell Mol Life Sci       Date:  2009-04-24       Impact factor: 9.261

Review 2.  Regulatory T cells in the immunotherapy of melanoma.

Authors:  Zhengxiao Ouyang; Hongwei Wu; Linqin Li; Yi Luo; Xianan Li; Gang Huang
Journal:  Tumour Biol       Date:  2015-10-30

3.  Transplantation tolerance: Clinical potential of regulatory T cells.

Authors:  Yannick D Muller; Jörg D Seebach; Leo H Bühler; Manuel Pascual; Dela Golshayan
Journal:  Self Nonself       Date:  2011-01-01

4.  DC expressing transgene Foxp3 are regulatory APC.

Authors:  Michael W Lipscomb; Jennifer L Taylor; Cristina J Goldbach; Simon C Watkins; Amy K Wesa; Walter J Storkus
Journal:  Eur J Immunol       Date:  2010-02       Impact factor: 5.532

Review 5.  The role of OX40-mediated co-stimulation in T-cell activation and survival.

Authors:  William L Redmond; Carl E Ruby; Andrew D Weinberg
Journal:  Crit Rev Immunol       Date:  2009       Impact factor: 2.214

6.  Neuropilin-1 expression identifies a subset of regulatory T cells in human lymph nodes that is modulated by preoperative chemoradiation therapy in cervical cancer.

Authors:  Alessandra Battaglia; Alexia Buzzonetti; Giovanni Monego; Laura Peri; Gabriella Ferrandina; Francesco Fanfani; Giovanni Scambia; Andrea Fattorossi
Journal:  Immunology       Date:  2007-11-20       Impact factor: 7.397

7.  Latency-associated peptide identifies a novel CD4+CD25+ regulatory T cell subset with TGFbeta-mediated function and enhanced suppression of experimental autoimmune encephalomyelitis.

Authors:  Mei-Ling Chen; Bo-Shiun Yan; Yoshio Bando; Vijay K Kuchroo; Howard L Weiner
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

Review 8.  Integrating costimulatory agonists to optimize immune-based cancer therapies.

Authors:  Angela D Pardee; Amy K Wesa; Walter J Storkus
Journal:  Immunotherapy       Date:  2009-03       Impact factor: 4.196

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.